Agilent Technologies has an average rating of overweight and mean price target of $181.89, according to analysts polled by FactSet.

<?xml encoding="utf-8" ?> Agilent Technologies Inc. A stock edged higher in Wednesday’s premarket trading after the company ...

Proscia, a Philadelphia-based digital pathology software company serving more than 4,000 laboratories, hospitals and clinics, ...

Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a ...

Oct 13 (Reuters) - Agilent Technologies said on Tuesday it would acquire pathology software maker Proscia for $240 million in ...

SANTA CLARA, California, October 13, 2026 — Agilent Technologies agreed to acquire digital pathology software provider ...

Agilent just set a fresh 52-week high at $177.75, 1.25% above the peak it made less than a week ago. The life sciences tools ...

Agilent Technologies has agreed to acquire Proscia, a provider of digital pathology software for clinical and life sciences customers, in an all-cash transaction valued at $240 million at closing plus ...

Agilent Technologies (NYSE:A) has had a better year this year after spending the best part of 2024 and 2025 in a genuine soft ...

Agilent Technologies is buying up the digital pathology software company Proscia in an all-cash transaction valued at $240 ...

Agilent Technologies is set to acquire Proscia, a digital pathology software provider, for $240 million in cash at closing, ...

Agilent will acquire digital pathology software provider Proscia, expanding Agilent’s presence in digital pathology workflows ...